Acyclovir in pharma franchise in Karnataka

Acyclovir in PCD pharma franchise in Manipur

Acyclovir in top pharma company in Bhopal

Acyclovir in pcd pharma supplier in Bhubaneswar

Acyclovir in phama franchise company in India
Acyclovir in phama distributor in Kolkata

Home/Products /acyclovir-500mg-injection

Aclonist 500 Injection

Composition : Acyclovir (500mg) Injection

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : 500mg

Price : ₹564/-

Aclonist 500 Injection contains Acyclovir (500mg), a potent antiviral medication used to combat infections caused by the herpes virus family. This includes herpes simplex (HSV), varicella-zoster virus (responsible for chickenpox and shingles), and other severe viral conditions. Acyclovir works by inhibiting viral DNA synthesis, preventing the virus from multiplying and spreading, while aiding the immune system in resolving the infection.

This injection is particularly useful in severe infections, immunocompromised individuals, or cases where oral administration is not feasible. Aclonist 500 provides fast-acting relief, making it an essential treatment in hospital settings for managing critical conditions such as herpes encephalitis, neonatal herpes, and systemic herpes infections. It is also commonly employed in patients undergoing chemotherapy, transplants, or those with weakened immune systems.

The 500mg dosage ensures robust antiviral activity, delivering efficacy in even challenging cases. Administered intravenously, it is closely monitored to ensure optimal therapeutic outcomes. Adequate hydration during its use is crucial to minimize the risk of kidney-related side effects.

Read More

About the Product

Aclonist 500 Injection contains Acyclovir (500mg), a potent antiviral medication used to combat infections caused by the herpes virus family. This includes herpes simplex (HSV), varicella-zoster virus (responsible for chickenpox and shingles), and other severe viral conditions. Acyclovir works by inhibiting viral DNA synthesis, preventing the virus from multiplying and spreading, while aiding the immune system in resolving the infection.

This injection is particularly useful in severe infections, immunocompromised individuals, or cases where oral administration is not feasible. Aclonist 500 provides fast-acting relief, making it an essential treatment in hospital settings for managing critical conditions such as herpes encephalitis, neonatal herpes, and systemic herpes infections. It is also commonly employed in patients undergoing chemotherapy, transplants, or those with weakened immune systems.

The 500mg dosage ensures robust antiviral activity, delivering efficacy in even challenging cases. Administered intravenously, it is closely monitored to ensure optimal therapeutic outcomes. Adequate hydration during its use is crucial to minimize the risk of kidney-related side effects.

Potential side effects include mild irritation at the injection site, headache, nausea, or fatigue. Rare side effects may include kidney dysfunction or allergic reactions.

Aclonist 500 Injection is indicated for the treatment of severe herpes infections, including herpes simplex, varicella-zoster, and infections in immunocompromised individuals.

Aclonist 500 should be administered under medical supervision only. Ensure adequate hydration to prevent kidney-related complications during treatment.

Store below 25°C in a cool, dry place, away from direct sunlight. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation